Currently out of the existing stock ratings of Lawrence Biegelsen, 83 are a BUY (56.08%), 51 are a HOLD (34.46%), 14 are a SELL (9.46%).

Lawrence Biegelsen

Work Performance Price Targets & Ratings Chart

Analyst Lawrence Biegelsen, currently employed at WELLS FARGO, carries an average stock price target met ratio of 70.86% that have a potential upside of 12.66% achieved within 162 days.

Lawrence Biegelsen’s has documented 698 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ZBH, Zimmer Biomet Holdings at 31-Oct-2024.

Wall Street Analyst Lawrence Biegelsen

Analyst best performing recommendations are on NARI (INARI MEDICAL ).
The best stock recommendation documented was for NVRO (NEVRO CORP) at 8/7/2024. The price target of $5.5 was fulfilled within 1 day with a profit of $0.67 (13.87%) receiving and performance score of 138.72.

Average potential price target upside

of $96.4 (26.29%) on EAR (EARGO ).
of $46.26 (11.25%) on COO (THE COOPER COMPANIES . COMMON STOCK).
of $40.63 (19%) on BDX (BECTON DICKINSON AND COMPANY).

ALC Alcon AG BDX Becton Dickinson and Company BSX Boston Scientific Corp DXCM DexCom EAR Eargo GKOS Glaukos Corp GMED Globus Medical ISRG Intuitive Surgical LUNG Pulmonx Corp MMSI Merit Medical Systems NPCE Neuropace NVRO Nevro Corp SWAV Shockwave Medical TFX Teleflex orporated TNDM Tandem Diabetes Care ZBH Zimmer Biomet Holdings NUVA NuVasive PODD Insulet

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

David Saxon (NEEDHAM)